When was Rivia founded?

Rivia was founded in 2002 and raised its 1st funding round 22 years after it was founded.

Where is Rivia located?

Rivia is headquartered in Switzerland.

Who is the current CEO of Rivia?

Erik Scalfaro of Rivia. They have also founded 1 company.

Is Rivia a funded company?

Rivia is a funded company, having raised a total of $18.2M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jun 12, 2024.

When was the latest funding round of Rivia?

Rivia's latest funding was a $***** Series A round on Mar 18, 2026, with participation from 5 investors. Its primary sector is Life Sciences Tech. In Switzerland, the Life Sciences Tech sector has seen $18.3M in funding in 2026 to date.

Where does Rivia rank among its competitors?

Rivia ranks 9th amongst 122 active competitors, of which 23 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Qureight, which secured $20M in Jul, 2026.

Who are the top competitors of Rivia?

Rivia's top competitors include Manifold AI, Komodo Health and Owkin. Among them, Qureight secured the most recent funding round in July, 2026.

Rivia - 2026 Company Profile, Team, Funding & Competitors

Rivia is a series A company based in Switzerland, founded in 2002 by Erik Scalfaro. It operates as a Provider of an AI-powered data analytics platform for clinical trials. Rivia has raised $18.2M in funding from Earlybird and Speedinvest. The company has 122 active competitors, including 23 funded and 4 that have exited. Its top competitors include companies like Manifold AI, Komodo Health and Owkin.

Company Details

Provider of an AI-powered data analytics platform for clinical trials. It integrates fragmented trial data from various sources into a standardized format, enabling real-time access and analysis. The platform offers visual intelligence tools and AI-powered conversational agents to facilitate data exploration and interpretation, streamlining clinical operations, safety monitoring, and executive oversight.

Key Metrics

Founded Year

2002

Location

Switzerland

Stage

Series A

Total Funding

$18.2M in 2 rounds

Latest Funding Round

Series A, Mar 18, 2026, $*****

Investors

Earlybird & 4 more

Ranked

9^th among 122 active competitors

Similar Companies

Manifold AI & 124 more

View Rivia's full profile

Rivia has raised a total funding of $18.2M over 2 rounds. Its first funding round was on Jun 12, 2024. Its latest funding round was a Series A round on Mar 18, 2026 for $*****. 5 investors participated in its latest round. Rivia has 5 institutional investors.

Here is the list of recent funding rounds of Rivia:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 18, 2026	3925778	Series A	9471323	4905106	8316492	9750239
Jun 12, 2024	2921010	Seed	9044818	8193283	Speedinvest	Amino Collective & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Rivia's funding rounds and investors

The founders of Rivia is Erik Scalfaro. Erik Scalfaro is the CEO of Rivia.

Here are the details of Rivia's key team members:

Erik Scalfaro: Co-Founder & CEO of Rivia.

View details of Rivia's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Rivia include Manifold AI, Komodo Health and Owkin. Here is the list of Top 10 competitors of Rivia, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Manifold AI 2016, Oakland (United States), Series B	Provider of an AI platform for life sciences research and development	$40M	TQ Ventures, Reach Capital & 13 others	72/100
2nd	Komodo Health 2014, New York City (United States), Series E	AI and cloud-based platforms provide data-driven insights to healthcare providers	$514M	Tiger Global Management, Coatue & 14 others	71/100
3rd	Owkin 2016, Paris (France), Series B	AI generative biology company to create the new standard of biology reasoning	$321M	F-Prime Capital, Frst Capital & 18 others	71/100
4th	Clarify 2015, San Francisco (United States), Series D	Company provides healthcare analytics and value-based payments platform services	$411M	Spark Capital, SoftBank Vision Fund & 22 others	64/100
5th	Apheris 2019, Berlin (Germany), Series A	Provider of data analytics solutions for life science industry	$20.8M	Octopus Ventures, OTB Ventures & 16 others	60/100
6th	Reliant AI 2023, Montreal (Canada), Acquired	Provider of an AI platform for biopharmaceutical research and development	$13.5M	Inovia Capital, Tola Capital & 6 others	58/100
7th	Qureight 2018, Cambridge (United Kingdom), Series B	AI enabled data curation platform for drug development	$31.2M	Molten Ventures, Playfair Capital & 21 others	57/100
8th	Seven Bridges Genomics 2009, Cambridge (United States), Acquired	Biomedical data analysis company accelerating healthcare research with software and analytics	$113M	First Star Ventures, Western Technology Investment ... & 3 others	54/100
9th	Rivia 2002, Switzerland, Series A	Provider of an AI-powered data analytics platform for clinical trials	$18.2M	Earlybird, Nina Capital & 3 others	52/100
10th	IDBS 1989, Guildford (United Kingdom), Acquired	Data management for research teams	$4.96M	Elaia	50/100